Aegon swings to €606 mln profit, doubles share buyback and lifts dividend

Aegon reported a significant financial turnaround for H1 2025, swinging to a €606 million net profit from a €65 million loss a year prior, with operating results climbing 19% to €845 million, largely driven by strong performance in its U.S. operations. The Dutch insurer demonstrated a commitment to shareholder returns by doubling its share buyback program to €400 million and raising its interim dividend by 19% to €0.19 per share. Furthermore, Aegon is actively reviewing a potential relocation of its legal domicile and head office to the United States, where approximately 70% of its operations are based, with a decision anticipated by its December Capital Markets Day.

Analysis

Aegon demonstrated a significant financial turnaround in the first half of 2025, swinging to a €606 million net profit from a €65 million loss in the prior-year period. This performance was underpinned by a 19% increase in its operating result to €845 million, largely driven by the U.S. segment, which grew its contribution by 23% to €627 million on the back of a 13% increase in new life sales. In a strong signal of confidence, the company doubled its share buyback program to €400 million and increased its interim dividend by 19% to €0.19 per share. However, this enhanced capital return has impacted key balance sheet metrics; operating capital generation after holding costs declined 8% to €423 million, and the group solvency ratio fell to 183% from 188%. Strategically, Aegon has initiated a pivotal review to potentially relocate its legal domicile to the United States, where 70% of its business is based, and make its NYSE listing primary. The outcome of this review, which could significantly alter the company's investment profile, is expected by its Capital Markets Day on December 10. Despite some pressure on capital metrics, the company reaffirmed it is on track to meet its 2025 financial targets.

Key Decisions for Investors

• The strong swing to profitability and substantial increase in capital returns, including a doubled share buyback, support a constructive view on the stock's fundamentals and management's confidence.
• Investors should closely monitor the strategic review concerning the potential relocation of the company's domicile to the U.S., as a decision by the December 10 Capital Markets Day could act as a significant catalyst for re-rating the stock.
• It is prudent to weigh the attractive shareholder returns against the noted decline in capital generation and the reduction in solvency ratios, which represent a key trade-off and a risk factor to monitor going forward.